Purpose: Keratoconus (KC) is a genetically heterogeneous corneal dystrophy. Previously, we performed 2 genome-wide linkage scans in a 4-generation autosomal dominant pedigree and repeatedly mapped a KC locus to a genomic region located on chromosome 5q overlapping the gene encoding the inhibitor of calpains, calpastatin (CAST). To test whether variants in CAST gene are involved in genetic susceptibility to KC, we performed genetic testing of polymorphic markers in CAST gene in family and casecontrol panels of patients with KC.
K eratoconus (KC, MIM 148300) is a noninflammatory corneal dystrophy characterized by progressive corneal thinning and resulting in moderate to marked visual impairment. 1 Although spectacle lenses may be used for vision correction in the early stages, corneal transplantation is often required for visual rehabilitation in severe cases. The prevalence of KC has been estimated between approximately 1:1200 2 and 1 in 2000 3 in the white population. It is a primary indication for cornea transplantation in Western developed countries. 4 Symptoms of KC usually manifest in the teens, and the progression slows after age 30, arresting around the fourth decade of life. 1, 5 There is accumulating evidence supporting a genetic basis for this disease, which includes multigeneration pedigrees with KC 1, 6 ; reports of probability for siblings of KC patients to develop KC were found to be in the range of 17% to 76% 7 ; and twin studies that demonstrate a 54% concordance rate among monozygotic twins. 8, 9 Most reported KC cases to be sporadic, whereas 6% to 23% of cases are reported to have a positive family history. 1, 10 In such cases, both autosomal dominant and recessive patterns of inheritance have been described. 11, 12 Genome-wide linkage analysis of affected pedigrees has demonstrated evidence of disease susceptibility genes mapping to several putative chromosomal loci, including: 16q22.3-q23.1, identified in 20 Finnish small pedigrees 13 ; 20q12, detected in an isolated population of Tasmania, Australia 14 ; 15q22.23-q24.2, identified in a large Northern Irish family, 15 recently attributed to the mutation in microRNA (miR-184) gene 16 ; 3p14-q13, identified in an Italian 2-generation autosomal dominant pedigree 17 ; and 5q21 by 2 studies. 18, 19 These extensive linkage studies provide further support for a genetic basis for KC while clearly demonstrating its genetically complex nature.
In addition to the linkage analysis, association testing and mutation analysis of candidate genes have been widely used to identify KC susceptibility genes. However, to date, only a limited number of candidate genes/or regions for KC have been reported, such as VSX1, [20] [21] [22] [23] HGF, 24 and most recently, LOX. 25 In addition, functional defects consequences of these associated variants have yet to be determined. [20] [21] [22] [23] A Genome-wide association study undertaken by our group also identified a novel region, overlapping candidate gene RAB3-GAP1, which contributes to the genetic susceptibility of KC. 26 Our group has identified a large 4-generation white pedigree and mapped the responsible gene to a novel 8.2 MB (mega bases or million base pairs) genomic region located at 5q14.3-q21.1, containing .50 known or predicted genes. 27 Recently, we performed additional genotyping of tightly spaced single-nucleotide polymorphisms (SNPs) in the linkage region, which allowed us to narrow the region down to approximately 5 MB (96-100 MB). 28 Gene coding for calpastatin, an endogenous inhibitor of calpains (CAST, OMIM 114090), was located in the 5q15 region overlapping the original linkage region and is still located under this narrowed linkage peak, thus making it a candidate gene for KC.
In the present study, we tested tightly spaced SNPs located in the CAST gene in 2 independent family-based and case-control-based white cohorts and found genetic evidence indicating potential involvement of CAST gene in both familial and sporadic KC.
MATERIALS AND METHODS

Study Panels KC Families
Family members of KC cases diagnosed at the Cornea Genetic Eye Institute were recruited to perform family-based studies. A total of 262 individuals from 40 families consisting of 131 KC patients and 131 unaffected family members were obtained for this study. This panel was ascertained through a clinically affected KC proband as a part of the longitudinal videokeratography and genetic study of KC at the Cedars-Sinai Medical Center in Los Angeles, CA.
Case-Control Cohort
An independent group of KC cases and controls was recruited as a part of the collaborative replication study. 26 Two hundred thirty-two independent KC cases were recruited at the Cornea Genetic Eye Institute, 26 cases at the Jules Stein Eye Institute, and 46 cases at the University Hospitals Eye Institute. This replication panel consisted of a total of 304 KC cases and 518 normal controls who were also recruited at the Cedars-Sinai Medical Center in Los Angeles, CA.
Controls used for this study were recruited at the Cedars-Sinai Medical Center and mostly consisted of spouses of patients enrolled into the KC genetic research study or spouses of individuals presenting for LASIK surgery screening and unaffected family members of KC patients. Absence of KC in these individuals was determined based on clinical examination and videokeratography. Some white subjects recruited locally for other inflammatory diseases (nonocular diseases) were also included as population controls.
Diagnosis
The diagnosis of KC was based on clinical examination and confirmed with videokeratography. All family members underwent clinical examinations, including slit-lamp biomicroscopy, cycloplegic retinoscopy, and fundus evaluations. The slit-lamp biomicroscope was used to examine whether there was stromal corneal thinning, Vogt striae, or a Fleischer ring. The retinoscopy examination was performed with a fully dilated pupil (20 minutes after phenylephrine 2.5% and cyclopentolate 1% drops had been instilled in the eye) to determine the presence or absence of retroillumination signs of KC, such as the oil droplet sign and scissoring of the red reflex. Videokeratography evaluation was also performed on each eye using the Topographic Modeling System. Subjects were assigned as having KC if they had at least 1 clinical sign of KC and a confirmatory videokeratography map with an asymmetric bowtie with skewed radial axis above and below the horizontal meridian (AB/SRAX) pattern. 1 Only patients with isolated KC were recruited, any affected individual or family members with any other corneal genetic disease, including forme fruste KC, or disease known to be associated with KC, were excluded.
Institutional review board approval was obtained at the Cedars-Sinai Medical Center. Written informed consents were obtained from all subjects after an explanation of the nature and possible consequences of study participation, including participation in this study and the establishment of a permanent lymphoblastoid cell lines. All study procedures were within the tenets of the Declaration of Helsinki.
DNA Collection
DNA was extracted from either blood samples or Epstein Barr virus-transformed lymphoblastoid cell lines following a standard protocol from Puregene (Gentra Systems, Inc., Minneapolis, MN). DNA concentration was measured by a NanoDrop spectrophotometer (NanoDrop Technologies, Rockland, DE) with 1 mL volume, and the DNA quality was estimated by the absorbance ratio of OD 260 /OD 280 . DNA sample was diluted in TE buffer (pH 8.0) and was stored at 220°C.
Genotyping
Initial Set of CAST SNPs
A total of 8 SNPs (rs9314177, rs17086561, rs4869307, rs151904, rs10515244, rs27654, rs3214019, and rs27765, Table 1 ) located in the introns of CAST gene were identified and genotyped using TaqMan allelic discrimination technology (Applied Biosystems Inc., Foster City, CA) in the family sample. The allelic discrimination assay was performed on an ABI 7000 Sequence Detection System with a reaction volume of 10 mL, containing 1· TaqMan Universal PCR Mater Mix, 2 pmol of each of 2 probes and 9 pmol of each of 2 polymerase chain reaction (PCR) primers, and 100 ng of sample DNA using PCR cycling conditions as suggested by the manufacturer. Ten percent of samples were duplicated for genotyping quality control.
Additional Set of SNPs for Fine-Mapping and Replication
Using the software Tagger as implemented in Haploview 29, 30 and data from the Centre d'Etude du Polymorphisme Humain population in the International HapMap project, release 2, 31, 32 we designed a panel of 14 SNPs in the CAST gene and genotyped them using the Custom iSelect Infinium BeadChip technology 33 (Illumina, Inc. San Diego, CA) in both family and case-control samples. Twelve SNPs were retained for analysis after clustering quality control ( Table 2 ). The average genotyping rate for samples genotyped on the iSelect platform and passing quality control was 99.98%. Genotyping concordance among 20 pairs of blind duplicates 100%. Two tentatively associated SNPs (rs4869307 and rs27654) identified in the family panel were also genotyped in case-control panel. SNP rs27654 was added to the iSelect BeadChip, as described previously. SNP rs4869307 was genotyped using predesigned TaqMan genotyping assay (Applied Biosystems, Inc.) with allelic discrimination on ABI 7900 Real-Time PCR System (Applied Biosystems, Inc.).
Statistical Analysis Testing for Genetic Association in Familial and Case-Control Panels
We tested each individual SNP for association with KC in both family and case-control panels using specific association tests designed for family and case-control studies, respectively. Association tests controlling for familial correlations by generalized estimating equation model were performed in families using the GWAF package. 34 The association analysis of a single SNP for case-control panel was performed by the PLINK program, v1.07 35 (http://pngu.mgh.harvard.edu/purcell/ plink/). Odds ratios and their SEs were calculated using SNP data under logistic regression models.
Meta-analysis
Meta-analysis of all SNPs obtained from the logistic regression models from the family cohort and replication cohort was calculated using an inverse-variance weighting by PLINK. 35 We applied a significance threshold of 2 · 10 23 based on Bonferroni correction for the number of SNPs tested. Regional association plots were generated by Locus-Zoom (http://cgs.sph.umich.edu/locuszoom/). 36 
RESULTS
SNPs in CAST Gene Are Associated With KC in a Family Panel
We analyzed 7 SNPs (rs9314177, rs4869307, rs151904, rs10515244, rs27654, rs3214019, and rs27765) in the introns of CAST gene and genotyped them in a family-based KC Minor allele frequency in cases (F_A) and controls (F_U) was presented separately. SNP with significant association in both panels is indicated in bold. *SNPs previously tested in family panel with no association in case-control panel.
cohort containing 262 white individuals in 40 pedigrees. Additionally, a selected eighth SNP rs17086561 was not polymorphic and was excluded from the analysis. We used the GWAF computer package 34 to test genotype-phenotype association with family data and identified 2 SNPs (rs4869307 and rs27654) associated with KC with nominally significant P values of 0.03 and 0.07, respectively (Table 1 ). These SNPs are located 64 KB apart.
Fine-Mapping and Replication Using Tagging SNPs
To perform a more comprehensive testing of the CAST gene, we used a tagging approach to identify SNPs with the highest potential to capture the greatest amount of common variation. 30 These optimized tag SNPs and 2 tentatively associated SNPs identified in the family panel were genotyped in both family and case-control panels of 822 samples (304 cases vs. 518 controls). In addition, we selected SNPs with the highest potential of successful genotyping on Illumina's iSelect platform.
We identified several SNPs with a nominal association in the family panel; however, only 1 SNP (rs4434401) was associated in both family and case-control panels with P values of 0.005 and 0.05, respectively ( Table 2) . Meta-analysis after combining 2 cohorts identified an association at rs4434401 with a P value of 0.002 (Fig. 1) . The association remained significant after Bonferroni correction with P = 0.04.
DISCUSSION
CAST (calpastatin) gene is located at the 5q15 chromosomal region under the linkage peak identified in the genomewide scan of a 4-generation KC family. 27 It is still located in the refined linkage region identified in a second linkage scan using tightly spaced SNPs. 28 We found that it contains SNP rs4434401 positively associated with KC in both familial and case-control panels, with statistically significant Bonferronicorrected meta P value of 0.04. These results provide initial evidence for CAST gene involvement in KC susceptibility. We are currently performing sequencing of the CAST gene to identify coding variants associated with KC risk alleles.
Calpastatin is a natural endogenous highly specific inhibitor of calpains, nonlysosomal intracellular proteases. 37 The calpains represent a well-conserved family of calciumdependent cysteine proteases. The mammalian calpains include 2 ubiquitous isoforms, calpain 1 (µ-calpain) and calpain 2 (m-calpain), and additional tissue-specific proteins, such as lens-specific calpains Lp82 and Lp85 38, 39 and corneal epithelium-specific variant of calpain 3 Cn94. 40 These proteins show broad substrate specificity and influence many aspects of cell physiology, including migration, proliferation, and apoptosis. 41 Animal studies suggest that the calpain/calpastatin system is present in the different parts of the eye, including cornea. Studies undertaken in rats have demonstrated a calpain/calpastatin system in corneal epithelium, where it is speculated to play a role in epithelial cell turnover and wound healing. 42 Immunohistochemical localization of calpains and calpastatin in the rabbit eye revealed the presence of µ-calpain, m-calpain, and calpastatin in corneal epithelial keratinocytes, endothelial cells, and corneal fibroblasts-keratocytes, although at variable levels. 43 These results suggest that functions of calpain/calpastatin system vary from being involved in cytoskeleton modifications, which occur in association with changes in cell shape and migratory activity and in mitotic activity during proliferation in the epithelium and in secretory processes in the other nonproliferating cells.
Mammalian calpastatin constitutes a part of the calpain/ calpastatin system, which is ubiquitously present in the majority of tissues; however, it also known to have multiple tissue-specific isoforms produced mostly by alternative splicing of the N-terminal exons. 44, 45 To get an insight on the calpastatin's expression in human eye tissues including cornea, we performed extensive examination of human expressed sequences located in the NCBI UniGene database (http://www.ncbi.nlm.nih.gov/unigene/) and in the Eyebrowse site (http://eyebrowse.cit.nih.gov/), which displays expressed sequence tags (ESTs) obtained from complementary DNA clones from eye tissues derived from NEIBank and other sources. We identified a number of ESTs matching to the CAST gene in mixed fetal and adult eye tissue and in different parts of the eye, such as trabecular meshwork, pterygium, lens, and cornea (Table 3 ). Corneal expression was limited to a single EST from corneal epithelial cells, a single EST from corneal stroma, and, remarkably, 5 ESTs from the unamplified human KC cornea library constructed by our group in collaboration with the National Eye Institute. 46 Based on sequence alignments between ESTs and known CAST transcripts located in the Reference RNA sequences (refseq_rna) database, we identified ESTs matching CAST transcript variant 2 (GenBank NM_173060.3), 6 (GenBank NM_001042440.2), and 11 (Gen-Bank NM_001190442.1), which encode isoforms b, f, and m, respectively (see Figure 1A , B, Supplemental Digital Content 1, http://links.lww.com/ICO/A96), and noncoding transcript 12 (GenBank NR_033798.1) to be expressed in normal and KC corneal tissue (Table 3 , see Figure 1A , Supplemental Digital Content 1, http://links.lww.com/ICO/A96). Interestingly, we also identified 2 ESTs derived from KC corneal tissue to be uniquely matched to CAST transcript variant 2 (isoform b, see Figure 1B , Supplemental Digital Content 1, http://links.lww.com/ICO/A96). Transcript variants 2, 11, and 12 have all been shown to be shorter than the longest CAST isoform f encoded by the longest CAST transcript variant 6 (see Figure 1A , Supplemental Digital Content 1, http:// links.lww.com/ICO/A96). Variant 2 differs in the 59 UTR, lacks a portion of the 59 coding region, initiates translation at a downstream start codon, and lacks in-frame exon compared with variant 6. Variant 11 has multiple differences in the coding region but maintains the reading frame compared with variant 6. Variant 12 has multiple differences compared with variant 6 and identified the Gene NCBI database as noncoding.
In contrast to cornea, in the lens tissue, we identified 3 ESTs nonuniquely mapped to variants 2, 6, and 11 but also 2 ESTs with no perfect match to any of CAST transcripts in refseq_rna database (Table 3) . Interestingly, blastn search of EST database using lens EST BU735062.1 identified a significant match to 2 testis ESTs similar to testis calpastatin (GenBank Q15786). These results suggest tissue-specific differences in the nature of calpastatin regulation of calpains in the different parts of the eye.
Abnormalities in the regulation of the calpain/calpastatin proteolytic system, including those due to the genetic defects, are associated with several human disorders, including cancer, 47 Alzheimer disease, 48 myocardial infarction, 49 diabetes, 50 muscular dystrophies, 51 such as muscular dystrophy LGMD2A, 52 and cataract formation. 53 The calpastatin to calpain ratio is an important factor in regulating calpain-induced proteolysis in tissues; however, because of additional important regulatory mechanisms, the effects are not always the same. High levels of calpastatin are implicated in lack of appreciable calpain-induced proteolysis in an experimental cataract model in primate and human lenses. 54 Overexpression of calpastatin has been shown to significantly improve necrotic processes in the dystrophic muscle of mdx mice, thus proving that inhibition of calpains might provide a therapeutic option for treatment of a progressive muscular dystrophy Duchenne Muscular Dystrophy. 55 It will be of great interest to assess the expression levels and activity of different isoforms of calpastatin in cornea tissue of KC patients and controls carrying risk allele of rs4434401 to determine whether this process is affected in the pathogenesis leading to corneal defects associated with KC. This could open a possibility of developing nonsurgical therapeutic options based on manipulation of the calpain/calpastatin system. 
